Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/2/2022 | $8.00 → $7.00 | Sector Perform | RBC Capital |
| 2/23/2022 | $58.00 → $52.00 | Buy | Stifel |
| 2/8/2022 | Buy → Neutral | Seaport Global | |
| 1/28/2022 | $51.00 → $45.00 | Equal-Weight | Morgan Stanley |
| 1/14/2022 | $56.00 → $51.00 | Equal-Weight | Morgan Stanley |
| 1/6/2022 | $45.00 | Hold | Loop Capital |
| 11/5/2021 | $57.00 → $60.00 | Overweight | Keybanc |
| 10/20/2021 | $12.00 → $9.00 | Outperform → Sector Perform | RBC Capital |
4 - Enovis CORP (0001420800) (Issuer)
4 - Enovis CORP (0001420800) (Issuer)
4 - Enovis CORP (0001420800) (Issuer)
8-K - Enovis CORP (0001420800) (Filer)
11-K - Enovis CORP (0001420800) (Filer)
8-K - Enovis CORP (0001420800) (Filer)
Wilmington, DE, April 05, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation ("Enovis" or the "Company") (NYSE:ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporation, announced today the completion of its previously announced separation (the "Separation") of its fabrication technology business into an independent, publicly traded company, ESAB Corporation ("ESAB") (NYSE:ESAB). Immediately following the Separation, Enovis effected its previously announced reverse stock split of all issued and outstanding shares of Enovis common stock at a one-for-three ratio. Enovis and ESAB common stock will each begin regular-way trading today, April 5, 2022, on t
NEW YORK, March 30, 2022 /PRNewswire/ -- ESAB Corp. (NYSE:ESAB) will be added to the S&P MidCap 400 effective prior to the opening of trading on Tuesday, April 5. Effective prior to the opening of trading on Wednesday, April 6, S&P MidCap 400 constituent PROG Holdings Inc. (NYSE:PRG) will replace Fiesta Restaurant Group Inc. (NASD: FRGI) in the S&P SmallCap 600. S&P MidCap 400 constituent Colfax Corp. (NYSE:CFX) is spinning off ESAB in a transaction expected to be completed on April 5. Post spin-off, Colfax will be renamed Enovis Corp. (NYSE:ENOV) and will remain in the S&P MidCap 400. PROG Holdings is more representative of the small-cap market space and Fiesta Restaurant Group is no longer
Wilmington, DE, March 28, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE:CFX), a leading diversified technology company which will renamed Enovis Corporation ("Enovis") following the expected April 4, 2022 consummation of the Company's previously announced spin-off of its fabrication technology business (the "Separation"), which will operate as ESAB Corporation ("ESAB") after the Separation, today announced the future composition of the full ESAB Board of Directors (the "Board"). Following the Separation, Mitchell P. Rales will serve as chairman of the Board, and current Colfax directors Patrick W. Allender, Rhonda L. Jordan, Didier Teirlinck and Rajiv Vinnakota will serve as directo
RBC Capital reiterated coverage of Canfor Pulp Products with a rating of Sector Perform and set a new price target of $7.00 from $8.00 previously
Stifel reiterated coverage of Colfax with a rating of Buy and set a new price target of $52.00 from $58.00 previously
Seaport Global downgraded Colfax from Buy to Neutral
Strong operating performance supported $0.06 EPS from continuing operations and $0.59 of adjusted EPSAchieved a strong quarter of cash flow, contributing to full year operating cash flow of $356 million and free cash flow of $277 millionPositioned for separation into two independent public companies near the end of the first quarter 2022 with strong growth outlooks for both businesses Wilmington, DE, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE:CFX), a leading diversified technology company, today announced its financial results for the fourth quarter and fiscal year 2021 and provided additional updates. The Company reported fourth quarter net income from c
Wilmington DE, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE:CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results for the fourth quarter and fiscal year 2021 on the morning of Tuesday, February 22, 2022. The Company will hold a conference call to discuss these results beginning at 8:00 a.m. Eastern on that day, which will be open to the public by calling +1-877-303-7908 (U.S. callers) and +1-678-373-0875 (International callers) and referencing the conference ID number 7466839 and through webcast via Colfax's website www.colfaxcorp.com under the "Investors" section. Colfax's financial results
Posted $0.17 EPS from continuing operations and $0.54 of adjusted EPSIncreased sales 20% to $966 million including a 15% organic sales-per-day improvementReported strong progress on integration of acquisitionsAnnounced continued progress to Q1 2022 separation including new post-separation name for MedTech growth company WILMINGTON, DE, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE:CFX), a leading diversified technology company, today announced its financial results for the third quarter of 2021 and provided other updates. The Company reported third quarter net income from continuing operations of $27 million, or $0
https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20220330-1451140/1451140_6cfx46.pdf
Colfax Corp's (NYSE:CFX) price target has been lowered to $52 (an upside of 41%) from $60 by KeyBanc analyst Jeffrey Hammond, following ESAB/Enovis's 2022 Investor Day to reflect broadly lower peer multiples. The analyst maintained an Overweight rating on CFX shares. Related: Colfax's Q4 Earnings Morgan Stanley also lowered its price target on Colfax to $41 (an upside of 11%) from $45 while maintaining the Equal-Weight ratings on the shares. Colfax recently announced the future composition of the board of the company, which will be renamed Enovis Corp., upon the consummation of the company's previously announced spin-off of its existing fabrication technology business, which will opera
SC 13G - Enovis CORP (0001420800) (Subject)
SC 13G/A - Colfax CORP (0001420800) (Subject)
SC 13G/A - Colfax CORP (0001420800) (Subject)